To win blockbuster spots on China's coverage list, Big Pharma offers big discounts
admin 19th July 2017 Uncategorised 0The Chinese government will add three dozen new drugs to its national insurance—including some big-selling foreign meds like Roche’s Herceptin, Celgene’s Revlimid and AstraZeneca’s Brilinta. The surprise? The move comes less than six months after China’s last coverage change. The not-so-surprising? Big price cuts.
More: To win blockbuster spots on China's coverage list, Big Pharma offers big discounts
Source: fierce